Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 10 member 2 (SLC10A2), also known as the apical sodium-dependent bile acid transporter (ASBT) or ileal bile acid transporter (IBAT), is a sodium/bile acid cotransporter primarily expressed in the ileum. It mediates the reabsorption of bile acids from the small intestine, playing a crucial role in enterohepatic circulation, cholesterol homeostasis, and lipid digestion. SLC10A2 is a therapeutic target for gastrointestinal disorders and metabolic diseases, with inhibitors under development to modulate bile acid recycling.
Inhibition of ASBT/IBAT, modulating bile acid recycling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 10 member 2.